Reka Kocsis

Lyme Diagnostics Ltd.

Our mission is to help patients of tick-borne diseases - especially Lyme borreliosis - get an earlier and more accurate diagnosis. Our breakthrough technology enables us to identify the infection directly from blood. Unlike other, indirect methods, we get a proof of infection directly, as early as a few weeks after the tick-bite, and even during or after a treatment. Having successfully finished clinical testing, DualDur (DD-LYME 4.0) method is soon going to be available across Europe. This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No. 805609.